A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Pfizer
Pfizer
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
National Institutes of Health Clinical Center (CC)
Kivu Bioscience Inc.
National Institutes of Health Clinical Center (CC)
Instil Bio
M.D. Anderson Cancer Center
AstraZeneca
BeOne Medicines
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Bristol-Myers Squibb
Exelixis
BeOne Medicines
Astellas Pharma Inc
Kestrel Therapeutics, Inc.
Amgen
Institut Claudius Regaud
National Institutes of Health Clinical Center (CC)
Vastra Gotaland Region
BioNTech SE
Kura Oncology, Inc.
Boehringer Ingelheim
Boehringer Ingelheim
Zymeworks BC Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Janssen Research & Development, LLC
Janssen Research & Development, LLC
National Cancer Institute (NCI)
AstraZeneca
AbbVie
National Cancer Institute (NCI)
RayzeBio, Inc.
Johnson & Johnson Enterprise Innovation Inc.
Eli Lilly and Company
Iambic Therapeutics, Inc
Amgen
Nammi Therapeutics Inc
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
EMD Serono
Plexium, Inc.
Anhui Provincial Hospital
The Methodist Hospital Research Institute
IDEAYA Biosciences
Memorial Sloan Kettering Cancer Center